 So, we focus on a disease called rheumatic fever and this can lead to heart damage called rheumatic heart disease. So, it's important to prevent rheumatic fever so that we can prevent rheumatic heart disease. But there's no specific diagnostic test for rheumatic fever. So, what our lab is doing is trying to improve the diagnosis of rheumatic fever. Usually, we'll use a combination of clinical symptoms as well as evidence of a preceding strep infection. So, strep is a bacteria that actually causes rheumatic fever. So, we need to see that someone has seen a strep infection to be able to diagnose them. But it's not a very good test and so there's a lot of problems with it. So, our lab is trying to develop a way to measure the antibodies more efficiently to try and overcome some of those problems with the diagnosis. So, my work is making a technology that would quickly and accurately measure antibodies to the strep antigen. And this will overcome some of the obstacles that current clinical labs face because they have two separate tests and it's just a bit of time consuming and not very accurate. Strep and rheumatic fever mainly affect in New Zealand, Māori and Pacific children. So, there's a huge disparity, health disparity there. So, it's really important that we can get on to this and help prevent rheumatic fever and rheumatic heart disease.